Role of sodium tungstate as a potential antiplatelet agent

Drug Design, Development and Therapy

Volumn 9, Issue , 2015, Pages 2777-2786

  Fernández Ruiz, Rebeca ^a,b   Pino, Marc ^c   Hurtado, Begoña ^d   de Frutos, Pablo García ^d   Caballo, Carolina ^c   Escolar, Ginés ^c   Gomis, Ramón ^a,b,c   Diaz Ricart, Maribel ^c  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d INST D INVESTIGACIONS B   (Spain)

Author keywords

Antiplatelet agents; Platelet adhesion; Protein tyrosine phosphatase 1B; Sodium tungstate

Indexed keywords

ANTITHROMBOCYTIC AGENT; COLLAGEN; PROTEIN TYROSINE PHOSPHATASE 1B; PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR; SODIUM TUNGSTATE; UNCLASSIFIED DRUG; PTPN1 PROTEIN, MOUSE; SODIUM TUNGSTATE(VI); TUNGSTEN DERIVATIVE;

AGGREGOMETRY; ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; IN VIVO STUDY; MALE; MOUSE; NONHUMAN; PLATELET FUNCTION ANALYZER PFA-100; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOELASTOMETRY; TURBIDIMETRY; VISCOELASTICITY; WILD TYPE; ANIMAL; BLOOD CLOTTING PARAMETERS; C57BL MOUSE; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; GENETICS; HUMAN; KNOCKOUT MOUSE; THROMBOCYTE; THROMBOELASTOGRAPHY; THROMBOSIS;

ANIMALS; BLOOD PLATELETS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; PROTEIN TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1; THROMBELASTOGRAPHY; THROMBOSIS; TUNGSTEN COMPOUNDS;

EID: 84930640480     PISSN: None     EISSN: 11778881     Source Type: Journal    
DOI: 10.2147/DDDT.S77221     Document Type: Article

References (46)

1. Jackson SP. Arterial thrombosis: insidious, unpredictable and deadly. Nat Med. 2011;17:1423–1436
2. Roth GJ, Stanford N, Majerus PW. Acetylation of prostaglandin synthase by aspirin. Proc Natl Acad Sci U S A. 1975;72:3073–3076
3. Foster CJ, Prosser DM, Agans JM, et al. Molecular identification and characterization of the platelet ADP receptor targeted by thienopyridine antithrombotic drugs. J Clin Invest. 2001;107:1591–1598
4. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med. 2001;345: 494–502
5. Wiviott SD, Braunwald E, McCabe CH, et al; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357:2001–2015
6. Garcia-Rodriguez LA, Hernandez-Diaz S, de Abajo FJ. Association between aspirin and upper gastrointestinal complications: systematic review of epidemiologic studies. Br J Clin Pharmacol. 2001;52:563–571
7. Peters RJ, Mehta SR, Fox KA, et al; Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) Trial Investigators. Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the clopidogrel in unstable angina to prevent recurrent events (CURE) study. Circulation. 2003;108:1682–1687
8. Claret M, Corominola H, Canals I, et al. Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation. Endocrinology. 2005;146:4362–4369
9. Barceló-Batllori S, Kalko SG, Esteban Y, Moreno S, Carmona MC, Gomis R. Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue. Mol Cell Proteomics. 2008;7: 378–393
10. Hanzu F, Gomis R, Coves MJ, et al. Proof-of-concept trial on the efficacy of sodium tungstate in human obesity. Diabetes Obes Metab. 2010;12:1013–1018
11. Barbera A, Rodriguez-Gil JE, Guinovart JJ. Insulin-like actions of tungstate in diabetic rats. Normalization of hepatic glucose metabolism. J Biol Chem. 1994;269:20047–20053
12. Huyer G, Liu S, Kelly J, et al. Mechanism of inhibition of protein tyrosine phosphatases by vanadate and pervanadate. Biol Chem. 1997; 272:843–851
13. Kuchay SM, Kim N, Grunz EA, Fay WP, Chishti AH. Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets. Mol Cell Biol. 2007;27:6038–6052
14. Arias-Salgado EG, Haj F, Dubois C, et al. PTP1B is an essential positive regulator of platelet integrin signalling. J Cell Biol. 2005;170:837–845
15. Klaman LD, Boss O, Peroni OD, et al. Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Mol Cell Biol. 2000;20:5479–5489
16. Gonzalez-Rodriguez A, Mas Gutierrez JA, Sanz-Gonzalez S, Ros M, Burks DJ, Valverde AM. Inhibition of PTP1B restores IRS1-mediated hepatic insulin signaling in IRS2-deficient mice. Diabetes. 2010;59:588–599
17. Kundu SK, Heilmann EJ, Sio R, Garcia C, Davidson RM, Ostgaard RA. Description of an in vitro platelet function analyzer-PFA-100. Semin Thromb Hemost. 1995;21:106–112
18. Shenkman B, Savion N, Dardik R, Tamarin I, Varon D. Testing of platelet deposition on polystyrene surface under flow conditions by the cone and platelet analyzer: role of platelet activation, fibrinogen and von Willebrand factor. Thromb Res. 2000;99:353–361
19. Diaz JA, Obi AT, Myers DD Jr, et al. Critical review of mouse models of venous thrombosis. Arterioscler Thromb Vasc Biol. 2012;32: 556–562
20. Galan AM, Lopez-Vilchez I, Diaz-Ricart M, et al. Serotonergic mechanisms enhance platelet-mediated thrombogenicity. Thromb Haemost. 2009;102:511–519
21. Escolar G, Bastida E, Castillo R, Ordinas A. Development of a computer program to analyze the parameters of platelet-vessel wall interaction. Haemostasis. 1986;16:8–14
22. Born GVR. Aggregation of blood platelets by adenosine-diphosphate and its reversal. Nature. 1962;194:927–929
23. Anderson L, Quasim I, Soutar R, Steven M, Macfie A, Korte W. An audit of red cell and blood product use after the institution of thromboelastometry in a cardiac intensive care unit. Transfus Med. 2006;16: 31–39
24. Weiss HJ, Turitto VT, Baumgartner HR. Platelet adhesion and thrombus formation on subendothelium in platelets deficient in glycoproteins IIb-IIIa, Ib, and storage granules. Blood. 1986;67:322–330
25. Lages B, Weiss HJ. Enhanced increases in cytosolic Ca2+ in ADP-stimulated platelets from patients with delta-storage pool deficiency: a possible indicator of interactions between granule-bound ADP and the membrane ADP receptor. Thromb Haemost. 1997;77:376–382
26. Born GV. Adenosine diphosphate as a mediator of platelet aggregation in vivo: an editorial view. Circulation. 1985;72:741–746
27. Inauen W, Baumgartner HR, Bombeli T, Haeberli A, Straub PW. Dose and shear rate-dependent effects of heparin on thrombogenesis induced by rabbit aorta subendothelium exposed to flowing human blood. Arteriosclerosis. 1990;10:607–615
28. Orvim U, Roald HE, Stephens RW, Roos N, Sakariassen KS. Tissue factor-induced coagulation triggers platelet thrombus formation as efficiently as fibrillar collagen at arterial blood flow conditions. Arterioscler Thromb. 1994;14:1976–1983
29. Salatti JA, Fenton J, Anton P, Sakariassen KS. Alpha-thrombin bound to extracellular endothelial matrix induces pronounced fibrin deposition and platelet thrombus growth in flowing non-anticoagulated human blood. Blood Coagul Fibrinolysis. 1994;5:561–566
30. White JG. Fine structural alterations induced in platelets by adenosine diphosphate. Blood. 1968;31:604–622
31. Kushner FG, Hand M, Smith SC Jr, et al. Focused updates: ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction and ACC/AHA/SCAI guidelines on percutaneous coronary intervention: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2009;54:2205–2241
32. Antman EM, Hand M, Armstrong PW, et al. Focused update of the ACC/AHA 2004 guidelines for the management of patients with ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2007;117:296–329
33. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, et al. Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2007;117:261–295
34. Jernberg T, Payne CD, Winters KJ, et al. Prasugrel achieves greater inhibition of platelet aggregation and a lower rate of non-responders compared with clopidogrel in aspirin treated patients with stable coronary artery disease. Eur Heart J. 2006;27:1166–1173
35. Mega JL, Close SL, Wiviott SD, et al. Cytochrome p-450 polymorphisms and response to clopidogrel. N Engl J Med. 2009;360:354–362
36. Bonello L, Tantry US, Marcucci R, et al; Working Group on High on-Treatment Platelet Reactivity. Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate. J Am Coll Cardiol. 2010;56:919–933
37. Egloff MP, Cohen PT, Reinemer P, Barford D. Crystal structure of the catalytic subunit of human protein phosphatase 1 and its complex with tungstate. J Mol Biol. 1995;254:942–959
38. Foster JD, Young SE, Brandt TD, Nordlie RC. Tungstate: a potent inhibitor of multifunctional glucose-6-phosphatase. Arch Biochem Biophys. 1998;354:125–132
39. Domingo JL. Vanadium and tungsten derivatives as antidiabeticagents: a review of their toxic effects. Biol Trace Elem Res. 2002;88:97–112
40. Barberà A, Gomis RR, Prats N, et al. Tungstate is an effective antidiabetic agent in streptozotocin-induced diabetic rats: a long-term study. Diabetologia. 2001;44:507–513
41. Barbera A, Fernandez-Alvarez J, Truc A, Gomis R, Guinovart JJ. Effects of tungstate in neonatally streptozotocin-induced diabetic rats: mechanism leading to normalization of glycaemia. Diabetologia. 1997;40:143–149
42. Giron MD, Caballero JJ, Vargas AM, Suarez MD, Guinovart JJ, Salto R. Modulation of glucose transporters in rat diaphragm by sodium tungstate. FEBS Lett. 2003;542:84–88
43. Rodriguez-Gallardo J, Silvestre RA, Egido EM, Marco J. Effects of sodium tungstate on insulin and glucagon secretion in the perfused rat pancreas. Eur J Pharmacol. 2000;402:199–204
44. Zafra D, Nocito L, Domínguez J, Guinovart JJ. Sodium tungstate activates glycogen synthesis through a non-canonical mechanism involving G-proteins. FEBS Lett. 2013;587:291–296
45. Brill A, Fuchs TA, Chauhan AK, et al. von Willebrand factor-mediated platelet adhesion is critical for deep vein thrombosis in mouse models. Blood. 2011;117:1400–1407
46. von Brühl ML, Stark K, Steinhart A, et al. Monocytes, neutrophils and platelets cooperate to initiate and propagate venous thrombosis in mice in vivo. J Exp Med. 2012;209:819–835.